Successful launch of the product YALDIGO - ÖCCO Symposium 2019
Haemo Pharma participated in the Austrian Chron Colitis Symposium from 27.09-28.09. in Bad Ischl.
We are pleased to present you our new product YALDIGO.
Yaldigo is used in chronic inflammatory bowel disease.
It consists of high-dose mesalazine and is taken only once a day.
Yaldigo treats and prevents inflammation throughout the colon and rectum.
For further questions please contact us directly!
Thank you again for your visit and interest!
